2003
DOI: 10.1126/science.1084920
|View full text |Cite
|
Sign up to set email alerts
|

A B Cell-Based Sensor for Rapid Identification of Pathogens

Abstract: We report the use of genetically engineered cells in a pathogen identification sensor. This sensor uses B lymphocytes that have been engineered to emit light within seconds of exposure to specific bacteria and viruses. We demonstrated rapid screening of relevant samples and identification of a variety of pathogens at very low levels. Because of its speed, sensitivity, and specificity, this pathogen identification technology could prove useful for medical diagnostics, biowarfare defense, food- and water-quality… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
164
0
7

Year Published

2005
2005
2016
2016

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 265 publications
(172 citation statements)
references
References 14 publications
1
164
0
7
Order By: Relevance
“…Detection limits for vaccinia virus (5 × 10 5 pfu/ml) on the AMP array were significantly higher than those obtained using a cell-based system [21] and an antibody-based array platform [22], as well as PCR-based tests [9,11]. However, detection limits determined here were in the same range as another biosensor-based assay that does not utilize concentration or amplification steps [23].…”
Section: Discussionmentioning
confidence: 55%
See 1 more Smart Citation
“…Detection limits for vaccinia virus (5 × 10 5 pfu/ml) on the AMP array were significantly higher than those obtained using a cell-based system [21] and an antibody-based array platform [22], as well as PCR-based tests [9,11]. However, detection limits determined here were in the same range as another biosensor-based assay that does not utilize concentration or amplification steps [23].…”
Section: Discussionmentioning
confidence: 55%
“…However, detection limits determined here were in the same range as another biosensor-based assay that does not utilize concentration or amplification steps [23]. Although assays were less sensitive for VEE, detection limits for VEE in the AMP-based assays were similar to or better than those of competing cell-or antibodybased technologies [21,22,24,25]. Several groups have previously described the antiviral effects of various AMPs and their derivatives on vaccinia virus [26][27][28].…”
Section: Discussionmentioning
confidence: 78%
“…To perform the assay, the live-cell sensor is mixed with the test sample, allowed to interact briefly, the mixture centrifuged, and the tube placed in a luminometer for reading. The system has been examined with foot-and-mouth disease virus and several bacterial pathogens including Yersinia pestis, Bacillus anthracis spores and E. coli 0157:H7, and is claimed to be capable of detecting as few as 50 colonyforming units within minutes (97).…”
Section: Cell-based Sensorsmentioning
confidence: 99%
“…Contact with the target pathogen causes cross-linking of surface-displayed IgM's, which triggers an intracellular biochemical cascade (release of calcium). In the presence of calcium, the aequorin emits light, providing a detectable output (97). To perform the assay, the live-cell sensor is mixed with the test sample, allowed to interact briefly, the mixture centrifuged, and the tube placed in a luminometer for reading.…”
Section: Cell-based Sensorsmentioning
confidence: 99%
“…A commonly used recognition elements in biosensors are antibodies (reviewed by [3]), although a variety of other bioorganic molecules have been also effectively used as an interface: peptides, enzymes, lectins, carbohydrates, nucleic acids, aptamers, recombinant proteins or molecularly imprinted polymers [4]. In a more recent detection format, the whole cells were explores as the binding entities [5,6]. No one of these types of recognition interfaces, however, could respond well to the sensor performance requirements.…”
Section: Introductionmentioning
confidence: 99%